Viatris Inc — Director's Dealing 2020

Nov 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Viatris Inc (VTRS)
CIK: 0001792044
Period of Report: 2020-11-20

Reporting Person: Narula Sanjeev (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-20	Restricted Stock Units	$0.00	A	21246	Acquired		Common Stock (21246)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7314	Direct

Footnotes

F1: Includes 7,314 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer Inc. ("Pfizer") to its stockholders of all of the issued and outstanding shares of Upjohn Inc. ("Upjohn") common stock held by Pfizer by way of pro rata dividend. On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer's Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction and Upjohn became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris").

F2: Each restricted stock unit ("RSU") represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 27, 2023.